T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis

References

• Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hailer DA. T-cell recognition of an immunodominant MBP epitope in multiple sclerosis. Nature 346, 183–187 (1990).
   PubMed Web of Science ®Google Scholar
• Steinman L. Multiple sclerosis: A co- ordinated immunological attack against myelin in the central nervous system. Cell 85,299–302 (1996).
   PubMed Web of Science ®Google Scholar
• Zhang J, Medaer R, Hashim G, Ying C, van den Berg-Loonen E, Raus J. Myelin basic protein-specific T-lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity and cytotoxicity. Ann. 1Veurol. 32,330-338 (1992).
   Google Scholar
• Hafler D. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. J. Clin. Invest. 104,527–529 (1999).
   Google Scholar
• Soldan SS, Belli R, Salem N et aZ Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3,1394-1397 (1997).
   Google Scholar
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol. 76, 6147–6154 (2002).
   Google Scholar
• Wucherpfennig K, Strominger J. Molecular mimicry in T-cell-mediated autoimmunity: viral peptides activate human T-cell clones specific for myelin basic protein. Cell 80, 695–705 (1995).
   PubMed Web of Science ®Google Scholar
• Hemmer B, Fleckenstein BT, Vergelli M et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T-cell clone. J. Exp. Med. 9, 1651–1659 (1997).
   Google Scholar
• Kozovska M, Zang YC, Aebischer I et al. T-cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur. f Immunot 6, 1894–901 (1998).
   Google Scholar
• Zamvil S, Nelson P Trotter J et aZ T-cell dones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355–358 (1985).
   PubMed Web of Science ®Google Scholar
• Allegretta M, Nicklas JA, Sriam S, Albertini RJ. T-cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247, 718–721 (1990).
   PubMed Web of Science ®Google Scholar
• Chou YK, Bourdette DN, Offner H et al. Frequency of T-cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis." Neuroimmunol. 38, 105–114 (1992).
   Google Scholar
• Zhang J, Markovic S, Lacet B, Raus J, Weiner HL, Hailer DA. Increased frequency of interleukin-2-responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis." E. Med 179, 973–984 (1994).
   Google Scholar
• Tejada-Simon MV, Yang D, Zang Y, Rivera V, Zhang J. T-cell reactivity to myelin antigens and their structural and functional properties at different clinical stages of multiple sderosis. Int. Immund 12, 1641–1650 (2000).
   Google Scholar
• Madsen LS, Andersson EC, Jansson L et al. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23, 343-347(1999).
   Google Scholar
• Ben-Nun A, Wekerle H, Cohen IR Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292, 60–61 (1981).
   PubMed Web of Science ®Google Scholar
• •The first demonstration of T-cell vaccination in an autoimmune animal model.
   Google Scholar
• Lider 0, Karin N, Shinitzky M, Cohen IR. Therapeutic vaccination against adjuvant arthritis using autoimmune T-cells treated with hydrostatic pressure. Proc. Natl Acad Sci. USA 84, 4577–4580 (1987).
   Google Scholar
• Beraud E, Kotake S, Caspi RR et al. Control of experimental autoimmune uveoretinitis by low dose T-cell vaccination. Cell Immuna 140, 112–122 (1992).
   PubMed Web of Science ®Google Scholar
• Hafler D, Cohen IR, Benjamine D, Weiner HL T-cell vaccination in multiple sclerosis: a preliminary report. Clin. Immuna Immunopath. 62, 307–312 (1992).
   PubMedGoogle Scholar
• Zhang J, Medaer R, Stinissen P Hailer DA, Raus J. MHC restricted clonotypic depletion of human myelin basic protein-reactive T-cells by T-cell vaccination. Science 261, 1451–1454 (1993).
   Google Scholar
• ••First T-cell vaccination clinical trial in MSpatients using myelin-reactive T-cell clones. The study demonstrated clonal depletion of circulating myelin-reactive T-cells and CD8+ cytolytic anti-idiotypic T-cell responses induced by T-cell vaccination.
   Google Scholar
• Zhang J, Raus J. T-cell vaccination in human autoimmune diseases: from laboratory to dinic. Hum. Immund 38, 87–96 (1993).
   PubMed Web of Science ®Google Scholar
• Zhang J, Vandevyver C, Stinissen P Raus J. In vivo clonotypic regulation of human myelin basic protein-reactive T-cells by T-cell vaccination." Immunot 155, 5808–5877 (1995).
   Google Scholar
• Medaer R, Stinissen P, Truyen L, Raus J, Zhang J. Depletion of myelin basic protein autoreactive T-cells by T-cell vaccination: Clinical trial in multiple sclerosis. Lancet 346, 807–808 (1995).
   PubMed Web of Science ®Google Scholar
• •Summarizes the clinical results for an independent clinical trial in MS patients.
   Google Scholar
• Correale J, Lund B, McMillan M, Ko DY, McCarthy K, Weiner LP T-cell vaccination in secondary progressive multiple sclerosis. 1Veuroimmuna 107, 130–139 (2000).
   Google Scholar
• •Summarizes the clinical results for an independent clinical trial in MS patients.
   Google Scholar
• Zhang JZ, Rivera VM, Tejada-Simon MV et al. T-cell vaccination in multiple sclerosis: results of a preliminary study. J. Neural. 249, 212–218 (2002).
   PubMed Web of Science ®Google Scholar
• •Summarizes the clinical results for an independent clinical trial in MS patients.
   Google Scholar
• Zang Y, Hong J, Rivera V, Killian J, Zhang J. Preferential recognition of hypervariable region sequence by anti-idiotypic T-cells induced by T-cell vaccination in patients with multiple sclerosis.' Immuna 164, 4011–4017 (2000).
   Google Scholar
• •Further evidence that CD8+ cytolytic anti-idiotypic T-cells induced by T-cell vaccination recognize the T-cell receptors and CDR3 region sequences of immunizing myelin-reactive T-cell clones in MS patients.
   Google Scholar
• Saruham-Direskeneli G, Weber F, Meinl E et aZ Human T-cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T-cell receptor l chain from a myelin basic protein-specific T-cell clone. Eur. j Immund 23, 530–540 (1993).
   Google Scholar
• Hong J, Zang Y, Rivera V, Zhang J. Reactivity and regulatory properties of anti-idiotypic antibodies induced by T-cell vaccination in patients with multiple sclerosis." Immund 165, 6858–6864 (2000).
   Google Scholar
• Zang Y, Hong J, Tejada-Simon M et al. Th2 immune regulation induced by T-cell vaccination in patients with multiple sclerosis. Eur.j Immunot 30, 908–913 (2000).
   Google Scholar
• Saeki Y, Mima T, Sakoda S et aZ Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc. Natl Acad. Sci. USA 89, 6157–6161 (1992).
   PubMed Web of Science ®Google Scholar
• Fujirnura H, Nakatsuji Y, Sakoda S et at Demyelination in severe combined immunodeficient mice by intracisternal injection of cerebrospinal fluid cells from patients with multiple sclerosis: neuropathological investigation. Acta Neuropatha (Bed) 93, 567–578 (1997).
   Google Scholar
• Hermans G, Medaer R, Raus J, Stinissen P Myelin reactive T-cells after T-cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations." Neuroimmund 102, 79–84 (2000).
   Google Scholar
• Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189, 1033–1042 (1999).
   PubMed Web of Science ®Google Scholar
• Vandenbark, AA, Hashim G, Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341, 541–544, (1989).
   PubMed Web of Science ®Google Scholar
• Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW Vaccination against experimental encephalomyelitis with T-cell receptor peptides. Science 246, 668–670 (1989).
   PubMed Web of Science ®Google Scholar
• Kumar V, Sercarz E. The involvement of T- cell receptor peptide-specific regulatory CD4+ T-cells in recovery from antigen-induced autoimmune disease.' Exp. Med. 178, 909–916 (1993).
   Google Scholar
• Vandenbark AA, Chou YK, V7hitham R et aZ Treatment of multiple sderosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat. Med 10, 1109–1115 (1996).
   Google Scholar
• •Imrnunoregulatory and preliminary clinical indications of peptide-based vaccination using T-cell receptor CDR2 peptides in patients with MS.
   Google Scholar
• Hong J, Zang Y, Tejada-Simon M et aL A common TCR sequence motif shared by myelin basic protein-reactive T-cells in patients with multiple sclerosis.' Immund 163, 3530–3538 (1999).
   PubMed Web of Science ®Google Scholar
• Kumar V, Sercarz E, Zhang J, Cohen IR T cell vaccination: From basics to the clinic. Trends Immund 22, 539–540 (2001).
   PubMedGoogle Scholar